Theravance Biopharma TBPH Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on trailing twelve months.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's free cash flow margin?
- Theravance Biopharma (TBPH) reported free cash flow margin of 221.9% in Q4 2025.
- How has Theravance Biopharma's free cash flow margin changed year-over-year?
- Theravance Biopharma's free cash flow margin increased by 1304.0% year-over-year, from -18.4% to 221.9%.
- What is the long-term trend for Theravance Biopharma's free cash flow margin?
- Over 5 years (2020 to 2025), Theravance Biopharma's free cash flow margin has grown at a -9.1% compound annual growth rate (CAGR), from -357.7% to 221.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.